AI-generated summary
In this mouse study, the authors examined whether low-level laser therapy applied to the skin over the airway could reduce airway hyperresponsiveness and lung inflammation after allergen challenge. They report that the treatment was associated with lower RhoA expression in bronchial muscle, fewer eosinophils, and reduced Th2 cytokines and STAT6 levels in the lungs. The findings come from an animal model, so their relevance to human asthma is not established.
- Who or what was studied
- Mice with allergic asthma induced by antigen challenge
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in mice, so the findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 30 mW
- Total energy
- 5.4 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Inflammation, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.